Robert W. Baird Forecasts Strong Price Appreciation for Veeva Systems (NYSE:VEEV) Stock

Veeva Systems (NYSE:VEEV) had its price target lifted by equities researchers at Robert W. Baird from $250.00 to $260.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the technology company’s stock. Robert W. Baird’s price objective would indicate a potential upside of 45.50% from the stock’s current price.

Other equities analysts have also issued reports about the stock. Zacks Research lowered shares of Veeva Systems from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 14th. Wall Street Zen downgraded shares of Veeva Systems from a “buy” rating to a “hold” rating in a report on Sunday, March 22nd. Barclays cut their price target on shares of Veeva Systems from $305.00 to $250.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Piper Sandler cut their price target on shares of Veeva Systems from $285.00 to $235.00 and set an “overweight” rating on the stock in a report on Thursday. Finally, William Blair reiterated an “outperform” rating on shares of Veeva Systems in a report on Tuesday, March 10th. Seventeen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $261.48.

Veeva Systems Stock Down 2.3%

Shares of Veeva Systems stock opened at $178.69 on Thursday. The firm has a market capitalization of $29.19 billion, a P/E ratio of 33.03, a PEG ratio of 0.81 and a beta of 0.95. The company has a 50 day moving average price of $166.29 and a 200 day moving average price of $196.71. Veeva Systems has a 52 week low of $148.05 and a 52 week high of $310.50.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. The firm had revenue of $882.95 million during the quarter, compared to analyst estimates of $857.73 million. Veeva Systems had a net margin of 28.44% and a return on equity of 13.80%. Veeva Systems’s revenue was up 16.3% on a year-over-year basis. During the same period last year, the firm posted $1.97 EPS. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, research analysts anticipate that Veeva Systems will post 6.45 earnings per share for the current fiscal year.

Insider Activity at Veeva Systems

In other news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the sale, the director owned 3,253 shares of the company’s stock, valued at $506,296.92. This trade represents a 18.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. NewEdge Advisors LLC lifted its holdings in Veeva Systems by 5.3% in the 1st quarter. NewEdge Advisors LLC now owns 9,340 shares of the technology company’s stock valued at $1,641,000 after purchasing an additional 466 shares in the last quarter. Caerus Investment Advisors LLC purchased a new position in Veeva Systems in the 1st quarter valued at $334,000. Allen Capital Group LLC lifted its holdings in Veeva Systems by 4.5% in the 1st quarter. Allen Capital Group LLC now owns 17,357 shares of the technology company’s stock valued at $3,049,000 after purchasing an additional 743 shares in the last quarter. Glenmede Trust Co. NA lifted its holdings in Veeva Systems by 2,994.9% in the 1st quarter. Glenmede Trust Co. NA now owns 41,348 shares of the technology company’s stock valued at $7,263,000 after purchasing an additional 40,012 shares in the last quarter. Finally, Edgestream Partners L.P. purchased a new position in Veeva Systems in the 1st quarter valued at $5,593,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Key Stories Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva reported Q1 revenue of about $882.9 million and adjusted EPS of $2.24, both ahead of estimates, showing continued demand and profitability improvement. Veeva Systems (VEEV) Q1 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Management issued Q2 revenue guidance of roughly $902 million-$905 million and EPS guidance of $2.21-$2.22, both above consensus, signaling confidence in near-term growth. Veeva Announces Fiscal 2027 First Quarter Results
• Positive Sentiment: Veeva highlighted AI innovations during the earnings call, which may support future product adoption and help the company deepen its competitive position in life sciences software. Veeva Systems Inc (VEEV) Q1 2027 Earnings Call Highlights: Surpassing Revenue Guidance and Unveiling AI Innovations
• Neutral Sentiment: Several summaries of the results emphasized that the quarter’s headline numbers were strong, but investors are still parsing the full transcript and details behind the outlook. Veeva Systems Inc. (VEEV) Q1 2027 Earnings Call Transcript
• Negative Sentiment: Despite the beat-and-raise report, some coverage noted the shares slipped after the announcement, suggesting the market may have been positioned for strong results or is focused on valuation and broader market sentiment. Veeva Shares Slip Despite Beating Q1 Estimates: Details

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.